title: Promotion and provision of colorectal cancer screening: a comparison of colorectal cancer control program grantees and nongrantees, 2011-2012.
abstract: BACKGROUND
  Since 2009, the Centers for Disease Control and Prevention (CDC) has awarded nearly $95 million to 29 states and tribes through the Colorectal Cancer Control Program (CRCCP) to fund 2 program components: 1) providing colorectal cancer (CRC) screening to uninsured and underinsured low-income adults and 2) promoting population-wide CRC screening through evidence-based interventions identified in the Guide to Community Preventive Services (Community Guide). CRCCP is a new model for disseminating and promoting use of evidence-based interventions. If the program proves successful, CDC may adopt the model for future cancer control programs. The objective of our study was to compare the colorectal cancer screening practices of recipients of CRCCP funding (grantees) with those of nonrecipients (nongrantees).
  
  
  METHODS
  We conducted parallel Web-based surveys in 2012 with CRCCP grantees (N = 29) and nongrantees (N = 24) to assess promotion and provision of CRC screening, including the use of evidence-based interventions.
  
  
  RESULTS
  CRCCP grantees were significantly more likely than nongrantees to use Community Guide-recommended evidence-based interventions (mean, 3.14 interventions vs 1.25 interventions, P < .001) and to use patient navigation services (eg, transportion or language translation services) (72% vs 17%, P < .001) for promoting CRC screening. Both groups were equally likely to use other strategies. CRCCP grantees were significantly more likely to provide CRC screening than were nongrantees (100% versus 50%, P < .001).
  
  
  CONCLUSIONS
  Results suggest that CRCCP funding and support increases use of evidence-based interventions to promote CRC screening, indicating the program's potential to increase population-wide CRC screening rates.
authors.affiliation: University of California at Los Angeles, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, 650 Charles Young Dr. South, A2-125 CHS, Box 956900, Los Angeles, CA 90095-6900. E-mail: amaxwell@ucla.edu.
authors.forename: Annette E
authors.initials: AE
authors.lastname: Maxwell
authors.affiliation: University of Washington, Seattle, Washington.
authors.forename: Peggy A
authors.initials: PA
authors.lastname: Hannon
authors.affiliation: Emory University, Atlanta, Georgia.
authors.forename: Cam
authors.initials: C
authors.lastname: Escoffery
authors.affiliation: University of Washington, Seattle, Washington.
authors.forename: Thuy
authors.initials: T
authors.lastname: Vu
authors.affiliation: University of Washington, Seattle, Washington.
authors.forename: Marlana
authors.initials: M
authors.lastname: Kohn
authors.affiliation: University of Texas Health Science Center at Houston, Houston, Texas.
authors.forename: Sally W
authors.initials: SW
authors.lastname: Vernon
authors.affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Amy
authors.initials: A
authors.lastname: DeGroff
mesh_terms: D000328:Adult; D002487:Centers for Disease Control and Prevention, U.S.; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*; D003625:Data Collection; D005380:Financing, Government; D006293:Health Promotion / Q000191:economics / Q000379:methods; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000379:methods; D014481:United States